IBI3011

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBI3011, covering 2025-12-19 to 2025-12-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic of IBI3011 [Phase 1]